Powered by CyTOF® technology

CyTOF Summit on Immuno-Oncology

Welcome and Introduction

→ Speakers: Andrew Quong, PhD, Standard BioTools™ Jonathan Irish, PhD, Vanderbilt University An introduction to our education...
Jul-29-2022

High-Content Cytometry for Investigation, Discovery and Therapeutic Development in Immuno-Oncology

→ Speaker: Roberto Spada, PhD, Standard BioTools™ A brief overview of the use of CyTOF® technology to date in immuno-oncology...
Jul-29-2022

Customizing Maxpar Direct Immune Profiling Assay and Maxpar Pathsetter for a Biotech Setting

→ Speaker: Pedro Falcon Estrada, MS, 2seventy bio™, Cambridge, MA Estrada discusses the significance of studying the proteome ...
Jul-26-2022

Simultaneous Mass Cytometry Quantification of Multiple Targets for Biotherapeutic Drug Development

→ Speaker: Chad Stevens, MS, Pfizer Worldwide Research & Development Stevens introduces an approach for simultaneous analysis ...
Jul-29-2022

Connecting Cells to Patient Outcomes

→ Speaker: Jonathan Irish, PhD, Vanderbilt University Irish presents his latest work on glioblastoma, focusing on contrasting ...
Jul-29-2022

An Unsupervised Learning Approach to Quantifying T Cell States From High-Plex Cytometry Data

→ Speaker: Dimitri Sidiropoulos, PhD Candidate, Johns Hopkins School of Medicine Cytometric studies surveying cell phenotypes ...
Jul-29-2022

Cellular Microenvironments in Stem Cell Niche Contacting Glioblastoma

→ Speaker: Rebecca Ihrie, PhD, Vanderbilt University Ihrie outlines how CyTOF® has been particularly useful in dissecting the ...
Jul-28-2022

Immune Correlates of GD2 CAR T Cell Expansion in Pediatric Osteosarcoma and Neuroblastoma Patients

→ Speaker: Sneha Ramakrishna, MD, Center for Cancer Cell Therapy, Stanford University School of Medicine Ramakrishna conducted...
Jul-29-2022

Panel Discussion

Moderator: Rebecca Ihrie, PhD, Vanderbilt University Panel members come together to jointly answer questions from the audience...
Aug-04-2022